Biodesix Stock Crashes Nearly 30% After Q3 Revenue Miss, Slashes 2026 Outlook
Biodesix shares fall after hours following third-quarter results and revised 2026 revenue guidance.
Share
Why It Matters
Biodesix made less money than people expected this quarter. When a company earns less, investors worry it might not grow as fast as planned.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.